Animalcare Group PLC
LSE:ANCR

Watchlist Manager
Animalcare Group PLC Logo
Animalcare Group PLC
LSE:ANCR
Watchlist
Price: 285 GBX 0.35%
Market Cap: £196.8m

Relative Value

The Relative Value of one ANCR stock under the Base Case scenario is hidden GBX. Compared to the current market price of 285 GBX, Animalcare Group PLC is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ANCR Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

ANCR Competitors Multiples
Animalcare Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Animalcare Group PLC
LSE:ANCR
196.6m GBP 2.4 66 15.5 40.8
US
Eli Lilly and Co
NYSE:LLY
1.1T USD 17.7 57 38.2 41
US
Johnson & Johnson
NYSE:JNJ
564.7B USD 6 21.1 14.7 18
CH
Roche Holding AG
SIX:ROG
284B CHF 4.6 30.3 12.8 14.9
US
Merck & Co Inc
NYSE:MRK
294.9B USD 4.5 16.2 10.1 11.8
CH
Novartis AG
SIX:NOVN
225.9B CHF 5.2 20.3 12.7 16.4
UK
AstraZeneca PLC
LSE:AZN
213.4B GBP 5.1 31.8 15.2 22.2
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK 4.2 12.8 8.9 10.4
US
Pfizer Inc
NYSE:PFE
153.2B USD 2.4 19.7 7.4 9.8
US
Bristol-Myers Squibb Co
NYSE:BMY
117.3B USD 2.4 19.4 6.9 9
P/E Multiple
Earnings Growth PEG
UK
Animalcare Group PLC
LSE:ANCR
Average P/E: 29.4
66
-15%
N/A
US
Eli Lilly and Co
NYSE:LLY
57
54%
1.1
US
Johnson & Johnson
NYSE:JNJ
21.1
6%
3.5
CH
Roche Holding AG
SIX:ROG
30.3
29%
1
US
Merck & Co Inc
NYSE:MRK
16.2
14%
1.2
CH
Novartis AG
SIX:NOVN
20.3
17%
1.2
UK
AstraZeneca PLC
LSE:AZN
31.8
38%
0.8
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
12.8
2%
6.4
US
Pfizer Inc
NYSE:PFE
19.7
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
19.4
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
UK
Animalcare Group PLC
LSE:ANCR
Average EV/EBITDA: 43.2
15.5
16%
1
US
Eli Lilly and Co
NYSE:LLY
38.2
34%
1.1
US
Johnson & Johnson
NYSE:JNJ
14.7
2%
7.3
CH
Roche Holding AG
SIX:ROG
12.8
5%
2.6
US
Merck & Co Inc
NYSE:MRK
10.1
7%
1.4
CH
Novartis AG
SIX:NOVN
12.7
6%
2.1
UK
AstraZeneca PLC
LSE:AZN
15.2
10%
1.5
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8.9
1%
8.9
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
6.9
-9%
N/A